{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:19:51Z","timestamp":1770499191777,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-05154-7","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:59:54Z","timestamp":1732082394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non pathological sweat test, pancreatic insufficiency and Cystic Fibrosis: an unusual case in a child with F508del-duplication of exons 1\u20133 CFTR genotype"],"prefix":"10.1186","volume":"24","author":[{"given":"Vito","family":"Terlizzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fevola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selene Del","family":"Vespa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Dolce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Scarallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Kleinfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Melotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Taccetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"5154_CR1","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMra2216474","volume":"389","author":"H Grasemann","year":"2023","unstructured":"Grasemann H, Ratjen F. Cystic fibrosis. N Engl J Med. 2023;389:1693\u2013707.","journal-title":"N Engl J Med"},{"key":"5154_CR2","first-page":"101637","volume":"54","author":"V Terlizzi","year":"2024","unstructured":"Terlizzi V, Farrell PM. Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians. Curr Probl Pediatr Adolesc Health Care. 2024;54:101637.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"5154_CR3","doi-asserted-by":"crossref","unstructured":"Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N et al. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017; 181S:S4-S15.e1.","DOI":"10.1016\/j.jpeds.2016.09.064"},{"key":"5154_CR4","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","volume":"10","author":"M Lopes-Pacheco","year":"2020","unstructured":"Lopes-Pacheco M. CFTR modulators: the changing Face of cystic fibrosis in the era of Precision Medicine. Front Pharmacol. 2020;10:1662.","journal-title":"Front Pharmacol"},{"key":"5154_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12890-018-0766-6","volume":"18","author":"V Terlizzi","year":"2018","unstructured":"Terlizzi V, Lucarelli M, Salvatore D, Angioni A, Bisogno A, Braggion C, et al. Clinical expression of cystic fibrosis in a large cohort of Italian siblings. BMC Pulm Med. 2018;18:196.","journal-title":"BMC Pulm Med"},{"key":"5154_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000029497","volume":"67","author":"J Zielenski","year":"2000","unstructured":"Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration. 2000;67:117\u201333.","journal-title":"Respiration"},{"key":"5154_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ajmg.10461","volume":"111","author":"F Salvatore","year":"2002","unstructured":"Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet. 2002;111:88\u201395.","journal-title":"Am J Med Genet"},{"key":"5154_CR8","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.1038\/s41598-020-62747-9","volume":"10","author":"A Castaldo","year":"2020","unstructured":"Castaldo A, Cernera G, Iacotucci P, Cimbalo C, Gelzo M, Comegna M, et al. TAS2R38 is a novel modifier gene in patients with cystic fibrosis. Sci Rep. 2020;10:5806.","journal-title":"Sci Rep"},{"key":"5154_CR9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJM199011293232203","volume":"323","author":"E Kerem","year":"1990","unstructured":"Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, et al. The relation between genotype and phenotype in cystic fibrosis\u2013 analysis of the most common mutation (delta F508). N Engl J Med. 1990;323:1517\u201322.","journal-title":"N Engl J Med"},{"key":"5154_CR10","doi-asserted-by":"publisher","unstructured":"Cecchetti M, Scarallo L, Lionetti P, Ooi CY, Terlizzi V. Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis. Paediatr Respir Rev. 2024:S1526-0542(24)00076-9. https:\/\/doi.org\/10.1016\/j.prrv.2024.07.004","DOI":"10.1016\/j.prrv.2024.07.004"},{"key":"5154_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2119\/molmed.2016.00010","volume":"22","author":"VM Sofia","year":"2016","unstructured":"Sofia VM, Da Sacco L, Surace C, Tomaiuolo AC, Genovese S, Grotta S, et al. Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis. Mol Med. 2016;22:300\u20139.","journal-title":"Mol Med"},{"key":"5154_CR12","first-page":"669","volume":"65","author":"V Terlizzi","year":"2013","unstructured":"Terlizzi V, De Gregorio F, Sepe A, Amato N, Arduino C, Casale A, et al. Brand new SPINK1 and CFTR mutations in a child with acute recurrent pancreatitis: a case report. Minerva Pediatr. 2013;65:669\u201372.","journal-title":"Minerva Pediatr"},{"key":"5154_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jcf.2017.12.003","volume":"17","author":"G Bergamini","year":"2018","unstructured":"Bergamini G, Tridello G, Calcaterra E, Ceri S, Tagliasacchi M, Bianchi F, et al. Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects. J Cyst Fibros. 2018;17:186\u20139.","journal-title":"J Cyst Fibros"},{"key":"5154_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jcf.2021.03.003","volume":"20","author":"D Treggiari","year":"2021","unstructured":"Treggiari D, Kleinfelder K, Bertini M, Tridello G, Fedrigo A, Pintani E, et al. Optical measurements of sweat for in vivo quantification of CFTR function in individual sweat glands. J Cyst Fibros. 2021;20:824\u20137.","journal-title":"J Cyst Fibros"},{"key":"5154_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jcf.2016.06.009","volume":"15","author":"G Tridello","year":"2016","unstructured":"Tridello G, Menin L, Pintani E, Bergamini G, Assael BM, Melotti P. Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis. J Cyst Fibros. 2016;15:579\u201382.","journal-title":"J Cyst Fibros"},{"key":"5154_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/thx.2009.125088","volume":"65","author":"N Derichs","year":"2010","unstructured":"Derichs N, Sanz J, Von Kanel T, Stolpe C, Zapf A, T\u00fcmmler B, Gallati S, Ballmann M. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data. Thorax. 2010;65:594\u20139.","journal-title":"Thorax"},{"key":"5154_CR17","doi-asserted-by":"publisher","first-page":"2102398","DOI":"10.1183\/13993003.02398-2021","volume":"60","author":"AC Kentgens","year":"2022","unstructured":"Kentgens AC, Latzin P, Anagnostopoulou P, Jensen R, Stahl M, Harper A, et al. Normative multiple-breath washout data in school-aged children corrected for sensor error. Eur Respir J. 2022;60:2102398.","journal-title":"Eur Respir J"},{"key":"5154_CR18","doi-asserted-by":"publisher","first-page":"108180","DOI":"10.1016\/j.isci.2023.108180","volume":"26","author":"K Kleinfelder","year":"2023","unstructured":"Kleinfelder K, Lotti V, Eramo A, Amato F, Lo Cicero S, Castelli G, et al. In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G\/A234D) in primary human rectal and nasal epithelial cells. iScience. 2023;26:108180.","journal-title":"iScience"},{"key":"5154_CR19","doi-asserted-by":"publisher","first-page":"10358","DOI":"10.3390\/ijms241210358","volume":"24","author":"K Kleinfelder","year":"2023","unstructured":"Kleinfelder K, Villella VR, Hristodor AM, Laudanna C, Castaldo G, Amato F, et al. Theratyping of the rare CFTR genotype A559T in rectal organoids and nasal cells reveals a relevant response to Elexacaftor (VX-445) and tezacaftor (VX-661) combination. Int J Mol Sci. 2023;24:10358.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"5154_CR20","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","volume":"16","author":"VK Singh","year":"2017","unstructured":"Singh VK, Schwarzenberg SJ. Pancreatic insufficiency in cystic fibrosis. J Cyst Fibros. 2017;16(Suppl 2):S70\u20138.","journal-title":"J Cyst Fibros"},{"issue":"Suppl 34","key":"5154_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/014107689809134S07","volume":"91","author":"M Wilschanski","year":"1998","unstructured":"Wilschanski M, Durie PR. Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med. 1998;91(Suppl 34):40\u20139.","journal-title":"J R Soc Med"},{"key":"5154_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jcf.2007.12.004","volume":"7","author":"R Tomaiuolo","year":"2008","unstructured":"Tomaiuolo R, Sangiuolo F, Bombieri C, Bonizzato A, Cardillo G, Raia V, et al. Epidemiology and a novel procedure for large scale analysis of CFTR rearrangements in classic and atypical CF patients: a multicentric Italian study. J Cyst Fibros. 2008;7:347\u201351.","journal-title":"J Cyst Fibros"},{"key":"5154_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcf.2013.09.007","volume":"13","author":"FJ Accurso","year":"2014","unstructured":"Accurso FJ, Van Goor F, Zha J, Stone AJ, Dong Q, Ordonez CL, et al. Sweat chloride as a biomarker of CFTR activity: proof of concept and Ivacaftor clinical trial data. J Cyst Fibros. 2014;13:139\u201347.","journal-title":"J Cyst Fibros"},{"key":"5154_CR24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","volume":"365","author":"BW Ramsey","year":"2011","unstructured":"Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, D\u0159ev\u00ednek P, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365:1663\u201372.","journal-title":"N Engl J Med"},{"key":"5154_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jcf.2016.02.015","volume":"16","author":"F Vermeulen","year":"2017","unstructured":"Vermeulen F, Le Camus C, Davies JC, Bilton D, Milenkovi\u0107 D, De Boeck K. Variability of sweat chloride concentration in subjects with cystic fibrosis and G551D mutations. J Cyst Fibros. 2017;16:36\u201340.","journal-title":"J Cyst Fibros"},{"key":"5154_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jcf.2023.04.018","volume":"22","author":"V Terlizzi","year":"2023","unstructured":"Terlizzi V, Dolce D. Variability of the sweat test in children with cystic fibrosis previously CRMS\/CFSPID: a retrospective monocenter experience. J Cyst Fibros. 2023;22:496\u20138.","journal-title":"J Cyst Fibros"},{"key":"5154_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13052-021-01060-1","volume":"47","author":"C Cimbalo","year":"2021","unstructured":"Cimbalo C, Tosco A, Terlizzi V, Sepe A, Castaldo A, Salvadori L, Raia V. Elevated sweat chloride test: is it always cystic fibrosis? Ital J Pediatr. 2021;47:112.","journal-title":"Ital J Pediatr"},{"issue":"8862","key":"5154_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0140-6736(93)91885-P","volume":"342","author":"A Augarten","year":"1993","unstructured":"Augarten A, Kerem BS, Yahav Y, Noiman S, Rivlin Y, Tal A, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849\u2009+\u200910\u00a0kb C\u2013>T mutation. Lancet. 1993;342(8862):25\u20136.","journal-title":"Lancet"},{"issue":"3 Pt 1","key":"5154_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1164\/ajrccm\/151.3_Pt_1.899","volume":"151","author":"B Stewart","year":"1995","unstructured":"Stewart B, Zabner J, Shuber AP, Welsh MJ, McCray PB Jr. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med. 1995;151(3 Pt 1):899\u2013903.","journal-title":"Am J Respir Crit Care Med"},{"key":"5154_CR30","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJM199410133311503","volume":"331","author":"WE Highsmith","year":"1994","unstructured":"Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med. 1994;331:974\u201380.","journal-title":"N Engl J Med"},{"key":"5154_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1399-0004.2007.00957.x","volume":"73","author":"V Paracchini","year":"2008","unstructured":"Paracchini V, Seia M, Coviello D, Porcaro L, Costantino L, Capasso P, et al. Molecular and clinical features associated with CFTR gene rearrangements in Italian population: identification of a new duplication and recurrent deletions. Clin Genet. 2008;73:346\u201352.","journal-title":"Clin Genet"},{"key":"5154_CR32","doi-asserted-by":"publisher","first-page":"e1506","DOI":"10.1002\/mgg3.1506","volume":"8","author":"C Ma","year":"2020","unstructured":"Ma C, Wang R, Li T, Li H, Wang B. Analysis of CNVs of CFTR gene in Chinese Han population with CBAVD. Mol Genet Genomic Med. 2020;8:e1506.","journal-title":"Mol Genet Genomic Med"},{"key":"5154_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/cge.12234","volume":"86","author":"MD Ramos","year":"2014","unstructured":"Ramos MD, Trujillano D, Olivar R, Sotillo F, Ossowski S, Manzanares J, et al. Extensive sequence analysis of CFTR, SCNN1A, SCNN1B, SCNN1G and SERPINA1 suggests an oligogenic basis for cystic fibrosis-like phenotypes. Clin Genet. 2014;86:91\u20135.","journal-title":"Clin Genet"},{"key":"5154_CR34","doi-asserted-by":"publisher","first-page":"e77114","DOI":"10.1371\/journal.pone.0077114","volume":"8","author":"JJ Wine","year":"2013","unstructured":"Wine JJ, Char JE, Chen J, Cho HJ, Dunn C, Frisbee E, et al. In vivo readout of CFTR function: ratiometric measurement of CFTR-dependent secretion by individual, identifiable human sweat glands. PLoS ONE. 2013;8:e77114.","journal-title":"PLoS ONE"},{"key":"5154_CR35","first-page":"4","volume":"10","author":"J Conti","year":"2022","unstructured":"Conti J, Sorio C, Melotti P. Organoid Technology and its role for Theratyping applications in cystic fibrosis. Child (Basel). 2022;10:4.","journal-title":"Child (Basel)"},{"key":"5154_CR36","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.celrep.2019.01.068","volume":"26","author":"G Berkers","year":"2019","unstructured":"Berkers G, van Mourik P, Vonk AM, Kruisselbrink E, Dekkers JF, de Winter-de Groot KM, et al. Rectal organoids enable personalized treatment of cystic fibrosis. Cell Rep. 2019;26:1701\u2013e17083.","journal-title":"Cell Rep"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05154-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-05154-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-05154-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:23:39Z","timestamp":1732091019000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-05154-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5154"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-05154-7","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"12 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An approval was obtained from the pediatric ethical committee of the Cystic Fibrosis center in Florence and for the Cystic Fibrosis Center AOUI of Verona (protocol#CFTR050).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Parents provided written informed consent for anonymous data processing and to participate in this case investigation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"752"}}